Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves
Petrini S, Ramadori G, Corradi A +7 more
Four DNA vaccines against BoHV-1 were evaluated for their efficacy in calves. Twelve\nanimals were divided into four groups which were injected with four different DNA\nvaccines: pVAX-tgD (Vaccine A); pVAX-tgD co-immunised with pVAX-48CpG (Vaccine B);\npVAX-UbiLacI-tgD-L (Vaccine C); pVAX-UbiLacI-tgD-L co-immunised with pVAX-48CpG\n(Vaccine D). Three additional calves were given the plasmid vector and served as controls.\nNinety days after the first vaccination all calves were challenge infected with BoHV-1.\nAll animals developed a severe form of infections bovine rhinotracheitis. Only the\ncalves given the pVAX-tgD co-immunised with pVAX-48CpG (Vaccine B) developed\nhumoral antibodies against BoHV-1 between 56 and 90 days after the first vaccination,\nwhereas in calves of other groups and in the controls, antibodies appeared only after the\ninfection. In the calves vaccinated with…